Ernexa Therapeutics Inc. (ERNA): auditor change — Ernexa Therapeutics dismisses Grant Thornton, appoints Haskell & White as auditor

Ernexa Therapeutics Inc.

Dismissal of Grant Thornton effective June 30, 2025; appointment of Haskell & White effective July 1, 2025, approved by Audit Committee.
Grant Thornton's reports for FY 2023 and 2024 included a going-concern explanatory paragraph but were otherwise unqualified.
No disagreements with Grant Thornton; only disclosed material weakness in FY 2023 internal controls from lack of technical accounting proficiency.
Grant Thornton provided a letter to the SEC regarding the dismissal, attached as Exhibit 16.1.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Ernexa Therapeutics Inc. dismissed Grant Thornton LLP as its auditor.

Action: dismissal
Auditor: Grant Thornton LLP

Exact text from the filing

ismissal of Former Independent Registered Public Accounting Firm On June 30, 2025, Ernexa Therapeutics Inc. (the “Company) dismissed Grant Thornton LLP (“Grant Thornton”) as the Company’s independent registered public accounting firm effective immediately.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Ernexa Therapeutics Inc. engaged Haskell & White LLP as its auditor.

Action: engagement
Auditor: Haskell & White LLP

Exact text from the filing

he statements made by the Company in this Item 4.01 insofar as they relate to Grant Thornton’s audit services and engagement as the Company’s independent registered public accounting firm. Grant Thornton has furnished a letter addressed to the SEC, a copy of which is attached hereto as Exhibit 16.1. (b) Appointment of New Independent Registered Public Accounting Firm On July 1, 2025, the Company engaged Haskell & White LLP (“Haskell & White”) as the Company’s independent registered

View on SEC.gov

Browse all auditor changes →

Ernexa Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-018009

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.